FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results equal to or better than the reduction of MRSA. This research is being assessed analytically and VESTEX® does intend to seek FDA clearance for specific claims […]
One thing that will haunt me and many health care personnel in both acute care and LTCFs forever is that so many people died without a family member at their bedside. I reached out to people in different disciplines, settings, and states. I wanted to know what lessons we’ve learned from the carnage caused by […]
Guest Author: Sherrie Dornberger RN, GDCN, CADDCT, CDP, CDONA, FACDONA Executive Director, National Association of Directors of Nursing Administration in Long Term Care (NADONA) As a professional nurse turned patient, I have personally experienced the …
Guest Author: Richard Gelula, MSW Executive Director, The National Consumer Voice for Quality Long-Term Care Among the most important responsibilities in caring for people in nursing homes and other long-term care settings is taking the time to learn w…
Guest Author: Nicole Brandt, PharmD, MBA, BCPP, CGP, FASCP Professor, Geriatric Pharmacotherapy, Pharmacy Practice and Science UMB School of Pharmacy Director, Clinical and Educational Programs of Peter Lamy Center Drug Therapy and Aging As a consultan…
Author: Nimalie Stone, MD Medical Epidemiologist, CDC’s Division of Healthcare Quality Promotion Improving the use of antibiotics in healthcare is critical to protect patients and reduce the threat of antibiotic resistance. In nursing homes, antibiotics are frequently prescribed medications; as many as 70% of residents receive antibiotics over the course of a year. However, a
Guest Author: Al Cardillo Executive Vice President Home Care Association (HCA) of New York State Early recognition of potential sepsis symptoms, rapid referral for confirmatory diagnosis, and swift intervention are imperative to protect patients. Healt…
Guest Author: Hallie C. Prescott, MD, MSc Pulmonary and Critical Care University of Michigan Ann Arbor VA Hospital I am an intensive care unit (ICU) doctor. Ever since I began medical training, I was drawn to the ICU. I love the challenge of caring for…
Guest Author: Jim O’Brien Vice President of Quality and Patient Safety Ohio Health Riverside Methodist Hospital I am biased about sepsis, but I will try to put that aside and present an argument for why people who have day jobs like me – hospital a…
Guest Author: Rommie L. Duckworth, LP Founder, Director New England Center for Rescue & Emergency Medicine, LLC Anya Coronel was born on April 18, 2009. A beautiful baby girl, Anya was born with spina bifida, a birth defect that, while corrected by surgery, would leave her prone to infections as well as a condition known
Guest Author: Orlaith Staunton Do you know that it is possible to prevent sepsis by the simple act of providing antibiotics and fluids when it is suspected? We didn’t know this when our beautiful son Rory Staunton died at just 12 years of age when em…
Guest Author: Pamela L. Popp MA JD DFASHRM CPHRM AIM DSA Executive Vice President/Chief Risk Officer Western Litigation In January of 2008, I joined the ranks of sepsis survivors. I too was placed on a ventilator, given months of antibiotic and antif…
Author: CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) Wondering how antibiotic resistance in foodborne bacteria has changed over time? You’re in luck. With CDC’s new interactive tool, NARMS Now: Human Data, you can view trends in antibiotic resistance over the past two decades for four bacteria transmitted commonly through food: Campylobacter, E. coli
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,